Literature DB >> 10081230

The Fas counterattack: cancer as a site of immune privilege.

J O'Connell1, M W Bennett, G C O'Sullivan, J K Collins, F Shanahan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10081230     DOI: 10.1016/s0167-5699(98)01382-6

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


× No keyword cloud information.
  47 in total

Review 1.  A portrait of the Bcl-2 protein family: life, death, and the whole picture.

Authors:  M Pellegrini; A Strasser
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.317

2.  Soluble Fas-ligand (sFasL) in human astrocytoma cyst fluid is cytotoxic to T-cells: another potential means of immune evasion.

Authors:  B Frankel; S L Longo; G W Canute
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

3.  Immune escape mechanisms in ALCL.

Authors:  J J Oudejans; R L ten Berge; C J L M Meijer
Journal:  J Clin Pathol       Date:  2003-06       Impact factor: 3.411

4.  Expression of the cellular FLICE-inhibitory protein (c-FLIP) protects Hodgkin's lymphoma cells from autonomous Fas-mediated death.

Authors:  A Dutton; J D O'Neil; A E Milner; G M Reynolds; J Starczynski; J Crocker; L S Young; P G Murray
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-19       Impact factor: 11.205

5.  CD34+ gene expression profiling of individual children with very severe aplastic anemia indicates a pathogenic role of integrin receptors and the proapoptotic death ligand TRAIL.

Authors:  Ute Fischer; Christian Ruckert; Bernd Hubner; Olaf Eckermann; Vera Binder; Tamam Bakchoul; Friedhelm R Schuster; Sylvia Merk; Hans-Ulrich Klein; Monika Führer; Martin Dugas; Arndt Borkhardt
Journal:  Haematologica       Date:  2012-02-07       Impact factor: 9.941

6.  Fas ligand expression in colon cancer: a possible mechanism of tumor immune privilege.

Authors:  Wei Zhang; Er-Xun Ding; Qiang Wang; Da-Qiao Zhu; Jin He; Yu-Li Li; Yuan-He Wang
Journal:  World J Gastroenterol       Date:  2005-06-21       Impact factor: 5.742

7.  Effects of general anesthesia with or without epidural block on tumor metastasis and mechanisms.

Authors:  Bin Yang; Feng Qian; Wenjia Li; Yang Li; Yangdong Han
Journal:  Oncol Lett       Date:  2018-01-26       Impact factor: 2.967

8.  Redirecting adaptive immunity against foreign antigens to tumors for cancer therapy.

Authors:  Wenxian Hu; John J Davis; Hongbo Zhu; Fengqin Dong; Wei Guo; Jian Ang; Henry Peng; Z Sheng Guo; David L Bartlett; Stephen G Swisher; Bingliang Fang
Journal:  Cancer Biol Ther       Date:  2007-08-12       Impact factor: 4.742

9.  Apoptosis and survival in high-grade astrocytomas as related to tumor Fas (APO-1/CD95) expression.

Authors:  Bruce Frankel; Sharon L Longo; Christopher Leach; Gregory W Canute; Timothy C Ryken
Journal:  J Neurooncol       Date:  2002-08       Impact factor: 4.130

10.  IRX-2, a novel immunotherapeutic, protects human T cells from tumor-induced cell death.

Authors:  M Czystowska; J Han; M J Szczepanski; M Szajnik; K Quadrini; H Brandwein; J W Hadden; K Signorelli; T L Whiteside
Journal:  Cell Death Differ       Date:  2009-01-30       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.